Myomectomy Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Myomectomy Market Analysis

The Myomectomy Market size is estimated at USD 0.64 billion in 2024, and is expected to reach USD 0.93 billion by 2029, growing at a CAGR of 8.10% during the forecast period (2024-2029).

An increase in the number of patients suffering from uterine fibroids is anticipated to be the key factor contributing to the growth of the myomectomy market. According to an article published by the International Journal of Reproduction, Contraception, Obstetrics, and Gynecology in July 2022, a study conducted in India showed that the incidence of fibroids was most common in 31-40 years of age, which was around 34.9%. The most commonly observed symptom for uterine fibroids was abdominal lump (41%) and abnormal uterine bleeding (24.1%). The prevalence of submucosal fibroids was 38.6%, intramural fibroids 19.3%, submucosal polyp 14.5%, seedling fibroid 13.9%, and subserosal fibroid 10.2%. Additionally, a rise in minimally invasive surgical procedures due to fewer complications and reduced hospital stays is anticipated to boost the market growth. Technological advancements such as the rise in robotic and laparoscopic-assisted surgeries to deliver quality and efficient treatment may also contribute to the growth of the myomectomy market.

According to an article published by MIS Journal in December 2022, uterine fibroids are considered a common benign smooth muscle tumor of the uterus that affects almost 70% of women until menopause. Risk factors of uterine fibroids include ethnicity, parity, early menarche, late menopause, family history, obesity, and hypertension. The presence of uterine fibroids is rarely life-threatening. However, they are often associated with symptoms affecting the quality of life, such as abnormal bleeding, pelvic pain, and urinary tract problems. The article also stated that robotic myomectomy has many advantages in uterine fibroid removal, such as lower blood loss, fewer complications, and shorter hospital stays over open surgery. The advantages of the wristed instruments, three-dimensional vision, and the incorporation of correct surgical techniques also emphasize the benefits of the robotic-assisted approach in large and numerous cases. Thus, the high burden of uterine fibroids and the increasing advantages of technologically advanced myomectomy procedures are expected to boost market growth.

The strategic activities by the market players, such as product launches and mergers and acquisitions, are expected to contribute to segmental growth over the forecast period. For instance, in November 2022, Olympus announced the launch of the moresolution Power Morcellator, manufactured by TROKAMED GmbH and available in the United States through a distribution agreement with Olympus America Inc. The moresolution Morcellator was designed for advanced gynecologic procedures with large, calcified tissue specimens. Olympus's Pneumoliner and the moresolution Morcellator can provide select patients with a laparoscopic surgical option.

Hence, factors such as the rising prevalence of uterine fibroids and the increasing advantages of technologically advanced myomectomy procedures are expected to boost market growth. However, the higher costs of new medical devices and complications associated with the procedure might restrict the growth of the market.

Myomectomy Market Trends

The Laparoscopic Segment is Expected to Hold a Significant Market Share over the Forecast Period

Myomectomy Industry Segmentation

Myomectomy is a surgical procedure to remove fibroids from the uterus. It allows the uterus to be left in place. It is for women who wish to get pregnant after receiving treatment for their fibroids. This procedure is considered the standard of care for removing fibroids and preserving the uterus. 

The myomectomy market is segmented by type, product, end user, and geography. By type, the market is segmented into abdominal, laparoscopic, hysteroscopic, and robotic. By product, the market is segmented into laparoscopic power morcellators, harmonic scalpels, laparoscopic sealers, and others. By end user, the market is segmented into clinics/hospitals and ambulatory surgical centers. By geography, the market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (USD) for all the segments mentioned above.